disease modeling and drug discovery
Register for ISSCR 2026 to discover the latest advances stem cell-based models for disease modeling and drug discovery, from organoid and engineered models to drug screening and evaluation, and AI-driven discovery.
-
Jinmiao Chen, PhD
Duke-NUS Medical School, Singapore
Presenting in New Approach Methodologies
-
Daniela Cornacchia, PhD
AstraZeneca, Sweden
Presenting in Precision Medicine and Drug Evaluation
-
Morgan Craig, PhD
Sainte-Justine University Hospital Azrieli Research Centre and Université de Montréal, Canada
Presenting in Biomanufacturing Stem Cell Therapies
-
Faranak Fattahi, PhD
-
Li Gan, PhD
Weill Cornell Medical College, USA
Presenting in Aging Models and Age-Related Diseases
-
Noo Li Jeon, PhD
Seoul National University, Korea
Presenting in Tissue and Organoid Engineering Session
-
Madeline Lancaster, PhD
Medical Research Council (MRC), UK
Presenting in Plenary I: Presidential Symposium
-
Pulin Li, PhD
-
Wendell A. Lim, PhD
-
Sasha Mendjan, PhD
Institute of Molecular Biotechnology, IMBA, Austria
Presenting in Advanced Organoid Models
-
Samira Musah, PhD
Duke University, USA
Presenting in Advanced Organoid Models
-
Josef Penninger, MD
Helmholtz Centre for Infection Research, Germany and The University of British Columbia, Canada
Presenting in Tissue and Organoid Engineering
-
Aviv Regev, PhD
Genentech, USA
Keynote speaker in Plenary III: Tissue Stem Cells in Physiology and Disease
-
Hongjun Song, PhD
University of Pennsylvania, USA
Presenting in Precision Medicine and Drug Evaluation
-
Amy Wong, PhD
The Hospital for Sick Children, Canada
Presenting in Plenary III: Tissue Stem Cells in Physiology and Disease
-
Peter Zandstra, PhD, FRSC, PEng
The University of British Columbia, Canada
Presenting in Engineering Cell Fate in Biological Systems